Recent studies have linked HMGB1 to the promotion of malignant behaviors in various cancers, including liver cancer, ovarian cancer, and non-small cell lung cancer, through the modulation of mitochondrial function, EMT, autophagy, and other pathways [11, 13, 18]. Here, HMGB1 is linked to liver cancer.